Psychopharmacology: number needed to treat: an underused measure of treatment effect.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Psychiatric Services

• Publication date

  2003-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1176/APPI.PS.54.2.145PMID 12556592
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Placebo response in studies of major depression: variable, substantial, and growing.

  2002cited by this paper
• Bulimia nervosa.

  2002cited by this paper
• Depressive disorders.

  2002cited by this paper
• Reporting number needed to treat and absolute risk reduction in randomized controlled trials.

  2002cited by this paper
• Intramuscular ziprasidone, 2 mg versus 10 mg, in the short-term management of agitated psychotic patients.

  2001cited by this paper
• Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial

  2001cited by this paper
• The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration

  2001cited by this paper
• Confidence intervals for the number needed to treat

  1998cited by this paper

• Comparison of antidepressant deprescribing strategies in individuals with clinically remitted depression: a systematic review and network meta-analysis.

  2026cites this paper
• Assisted reproductive technology and the risk of birth defects mediated by multifetal pregnancy: evidence from the China Birth Cohort Study.

  2024cites this paper
• Comparing Pharmacotherapies for ADHD in Adults: Evidence From Outcome-Focused Analysis of Food and Drug Administration Drug Label Registration Trials

  2024cites this paper
• Treating spondyloarthritis early: does it matter? Results from a systematic literature review.

  2022cites this paper
• Ketogenic diet reduces alcohol withdrawal symptoms in humans and alcohol intake in rodents

  2021cites this paper
• Benefit–Risk Assessment of Galcanezumab Versus Placebo for the Treatment of Episodic and Chronic Migraine Using the Metrics of Number Needed to Treat and Number Needed to Harm

  2021cites this paper
• Stratified psychiatry: Tomorrow's precision psychiatry?

  2021cites this paper
• Group cognitive-behavioural therapy for perinatal anxiety disorders: Treatment development, content, and pilot results

  2021cites this paper
• Appraising esketamine nasal spray for the management of treatment-resistant depression in adults: Number needed to treat, number needed to harm, and likelihood to be helped or harmed.

  2020cites this paper
• The Effect of Mindfulness-Based Training on Stress, Anxiety, Depression, and Job Satisfaction Among Ward Nurses: A Randomized Control Trial.

  2020cites this paper
• Effectiveness of Peer-Supported Computer-Based CBT for Depression Among Veterans in Primary Care.

  2020cites this paper
• Efficacy and mediators of a group cognitive-behavioral therapy for hoarding disorder: A randomized trial.

  2019influential citation
• Derivation of a psychosocial clinical prediction rule to target sexual healthcare among women of reproductive age attending British General Practices

  2018cites this paper
• Reply to letter

  2018cites this paper
• Pimavanserin for the treatment of Parkinson’s disease psychosis: number needed to treat, number needed to harm, and likelihood to be helped or harmed

  2017cites this paper
• Brief cognitive-behavioural therapy for patients in the community with schizophrenia: randomised controlled trial in Beijing, China.

  2017cites this paper
• Secondary Effects of an Alcohol Prevention Program Targeting Students and/or Parents.

  2016cites this paper
• Using SAFMEDS to assist language learners to acquire second-language vocabulary

  2016cites this paper
• Effects of a DVD-Delivered Mindfulness-Based Intervention for Stress Reduction in Medical Students: A Randomized Controlled Study

  2015cites this paper
• Effect Size, Measures of

  2015cites this paper
• Effects of a brief mindfulness-based intervention program for stress management among medical students: the Mindful-Gym randomized controlled study

  2015cites this paper
• Efficacy of extended release quetiapine fumarate monotherapy in elderly patients with major depressive disorder: secondary analyses in subgroups of patients according to baseline anxiety, sleep disturbance, and pain levels

  2014cites this paper
• Extended-Release Quetiapine Fumarate (Quetiapine Xr) as Adjunctive Therapy in Patients with Generalized Anxiety Disorder and A history of Inadequate Treatment Response: A Randomized, Double-Blind Study

  2014cites this paper
• Effectiveness of the 'Healthy School and Drugs' prevention programme on adolescents' substance use: a randomized clustered trial.

  2014cites this paper
• The efficacy and effectiveness of psychological treatments for mood, anxiety, and related disorders.

  2014cites this paper
• Extended-release quetiapine fumarate (quetiapine XR) as adjunctive therapy in patients with generalized anxiety disorder and a history of inadequate treatment response: a randomized, double-blind study.

  2013cites this paper
• Predictive validity performance indicators in violence risk assessment: a methodological primer.

  2013cites this paper
• Quetiapine XR monotherapy in major depressive disorder: a pooled analysis to assess the influence of baseline severity on efficacy

  2013cites this paper
• Double‐blind, randomized study of extended release quetiapine fumarate (quetiapine XR) monotherapy in older patients with generalized anxiety disorder

  2013cites this paper
• Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant – what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

  2013cites this paper
• Efficacy and tolerability of extended release quetiapine fumarate monotherapy in the acute treatment of generalized anxiety disorder: a randomized, placebo controlled and active-controlled study

  2012cites this paper
• Using precision teaching strategies and tactics to increase essential skill fluency

  2012cites this paper
• Randomized, double-blind study of the efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in elderly patients with major depressive disorder.

  2012cites this paper
• EXTENDED RELEASE QUETIAPINE FUMARATE IN MAJOR DEPRESSIVE DISORDER: ANALYSIS IN PATIENTS WITH ANXIOUS DEPRESSION

  2012cites this paper
• Extended Release Quetiapine Fumarate (Quetiapine XR) as Adjunct Therapy in Patients with Generalized Anxiety Disorder and a History of Inadequate Treatment Response: A Randomized, Double-Blind Study

  2012cites this paper
• Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant – what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?

  2012cites this paper
• Psychopharmacology of schizophrenia in children and adolescents.

  2011cites this paper
• Second-generation antipsychotics in major depressive disorder: update and clinical perspective

  2011cites this paper
• Extended Release Quetiapine Fumarate (Quetiapine XR) as Adjunct Therapy in Patients with Generalized Anxiety Disorder and a History of Inadequate Treatment Response: A Randomized, Double-Blind Study.

  2011cites this paper
• Psychiatric Pharmacotherapy Update

  2011cites this paper
• Why target early adolescents and parents in alcohol prevention? The mediating effects of self-control, rules and attitudes about alcohol use.

  2011cites this paper
• Long-term effects of a parent and student intervention on alcohol use in adolescents: a cluster randomized controlled trial.

  2011cites this paper
• Prevention of alcohol use in early adolescents: A joint venture of school and parents

  2011cites this paper
• Intensive Early Intervention

  2011cites this paper
• Outcomes of anti-bullying intervention for adults with intellectual disabilities.

  2010influential citation
• Measuring social functioning with the personal and social performance scale in patients with acute symptoms of schizophrenia: interpretation of results of a pooled analysis of three Phase III trials of paliperidone extended-release tablets.

  2010cites this paper
• Using participant data to extend the evidence base for intensive behavioral intervention for children with autism.

  2010cites this paper
• Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV‐1‐infected patients treated with abacavir

  2010cites this paper
• Cognitive and Adaptive Behavior Outcomes of Behavioral Intervention for Young Children With Intellectual Disability

  2010cites this paper
• Intervention for Young Children With Intellectual Disability Cognitive and Adaptive Behavior Outcomes of Behavioral

  2010cites this paper
• An effect size primer: A guide for clinicians and researchers.

  2009cites this paper
• COST-EFFECTIVENESS OF AN INTERNET-DELIVERED COGNITIVE-BEHAVIORAL TREATMENT FOR ERECTILE DYSFUNCTION

  2009cites this paper
• Extended Release Quetiapine Fumarate Monotherapy for Major Depressive Disorder: Results of a Double-Blind, Randomized, Placebo-Controlled Study

  2009cites this paper
• Preventing heavy alcohol use in adolescents (PAS): cluster randomized trial of a parent and student intervention offered separately and simultaneously.

  2009cites this paper
• Adding Comments and Notes to Your PDF

  2009cites this paper
• Assessing treatment effects in clinical trials with the Discan metric of the Sheehan Disability Scale

  2008cites this paper
• Early childhood OCD: preliminary findings from a family-based cognitive-behavioral approach.

  2008cites this paper
• Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.

  2008cites this paper
• TMS – the beginning of the end or the end of the beginning?

  2007cites this paper
• Ziprasidone for schizophrenia and bipolar disorder: a review of the clinical trials.

  2007cites this paper
• Tailored psychotherapy for patients with functional neurological symptoms: a pilot study.

  2007cites this paper
• Reviewing CATIE for clinicians:balancing benefit and risk using evidence-based medicine tools

  2007cites this paper
• Transcranial magnetic stimulation

  2006cites this paper
• Schizophrenia, Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and number needed to treat: how can CATIE inform clinicians?

  2006cites this paper
• Preferences for different methods of communicating information regarding adjuvant chemotherapy for breast cancer

  2005cites this paper
• Efficacy of Cognitive—Behavioural Therapy for Children and Adolescents With Anxiety Disorders

  2005cites this paper
• Geriatric psychiatry Advances and debates in geriatric psychopharmacology

  2005cites this paper
• The Pediatric Obsessive-Compulsive Disorder Treatment Study: Rationale, Design, and Methods

  2003cites this paper
• Child and Adolescent Psychiatry and Mental Health the Pediatric Obsessive-compulsive Disorder Treatment Study Ii: Rationale, Design and Methods

  year unknowncites this paper